Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss. (öffnet neues Fenster)

Arroliga AC, Guntupalli KK, Beaver JS, Langholff W, Marino K, Kelly K

Quelle‎: Crit Care Med 2009;37(4):1299-307.

Indiziert‎: PubMed 19242343

DOI‎: 10.1097/CCM.0b013e31819cec94

https://www.ncbi.nlm.nih.gov/pubmed/19242343 (öffnet neues Fenster)

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (öffnet neues Fenster)

Ball AM, Winstead PS.

Quelle‎: Pharmacotherapy 2008;28(11):1383-90.

Indiziert‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (öffnet neues Fenster)

Reducing postburn injury anemia in a Jehovah's Witness patient. (öffnet neues Fenster)

Barsun A, Sen S, Palmieri TL, Greenhalgh DG

Quelle‎: J Burn Care Res 2014;35(4):e258-61.

Indiziert‎: PubMed 24121804

DOI‎: 10.1097/BCR.0b013e3182a366c5

https://www.ncbi.nlm.nih.gov/pubmed/24121804 (öffnet neues Fenster)

A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit. (öffnet neues Fenster)

Brophy GM, Sheehan V, Shapiro MJ, Lottenberg L, Scarlata D, Audhya P; ASSESS Study Group and Amgen Inc

Quelle‎: Clin Ther 2008;30(12):2324-34.

Indiziert‎: PubMed 19167591

DOI‎: 10.1016/j.clinthera.2008.12.024

https://www.ncbi.nlm.nih.gov/pubmed/19167591 (öffnet neues Fenster)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (öffnet neues Fenster)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Quelle‎: Transplant Proc 2015;47(8):2548-51.

Indiziert‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (öffnet neues Fenster)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (öffnet neues Fenster)

Charles A, Purtill M, Napolitano LM.

Quelle‎: Anaesth Intensive Care 2006;34(6):793-6.

Indiziert‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (öffnet neues Fenster)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (öffnet neues Fenster)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Quelle‎: Crit Care Med 1999;27(11):2346-50.

Indiziert‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (öffnet neues Fenster)

Erythropoietin for critically ill trauma patients: a missed opportunity? (öffnet neues Fenster)

Corwin HL, Napolitano LM

Quelle‎: J Trauma Acute Care Surg 2014;77(5):774-9.

Indiziert‎: PubMed 25494432

DOI‎: 10.1097/TA.0000000000000442

https://www.ncbi.nlm.nih.gov/pubmed/25494432 (öffnet neues Fenster)

Postoperative management of severe acute anemia in a Jehovah's Witness. (öffnet neues Fenster)

de Araújo Azi LM, Lopes FM, Garcia LV

Quelle‎: Transfusion 2014;54(4):1153-7.

Indiziert‎: PubMed 24117834

DOI‎: 10.1111/trf.12424

https://www.ncbi.nlm.nih.gov/pubmed/24117834 (öffnet neues Fenster)

Restrictive transfusion in geriatric trauma patients. (öffnet neues Fenster)

DeLeon AN, Uecker JM, Stafford SV, Ali S, Clark A, Brown CV

Quelle‎: Am Surg 2016;82(1):85-8.

Indiziert‎: PubMed 26802863

https://www.ncbi.nlm.nih.gov/pubmed/26802863 (öffnet neues Fenster)

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. (öffnet neues Fenster)

Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG

Quelle‎: J Trauma 1998;44(2):361-7.

Indiziert‎: PubMed 9498512

DOI‎: 10.1097/00005373-199802000-00023

https://www.ncbi.nlm.nih.gov/pubmed/9498512 (öffnet neues Fenster)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (öffnet neues Fenster)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Quelle‎: Crit Care 2005;9(5):R508-15.

Indiziert‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (öffnet neues Fenster)

Management of a Jehovah's Witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. (öffnet neues Fenster)

Hong T, Shander A, Agarwal S, Castresana M.

Quelle‎: A A Case Rep 2015;4(10):127-31.

Indiziert‎: PubMed 25974416

DOI‎: 10.1213/XAA.0000000000000144

https://www.ncbi.nlm.nih.gov/pubmed/25974416 (öffnet neues Fenster)

Management strategies for perioperative anaemia in the severely burn-injured Jehovah's Witness patients who decline a blood transfusion: a systematic review with illustrative case reports. (öffnet neues Fenster)

Jung M, Harish V, Wijewardena A, Kerridge I, Gillies R

Quelle‎: Burns. 2023 49(3):716-29. Epub 2022 Jul 18.

Indiziert‎: PubMed 35941026

DOI‎: 10.1016/j.burns.2022.07.002

https://pubmed.ncbi.nlm.nih.gov/35941026/ (öffnet neues Fenster)

Long-term ECMO treatment in Jehovah's Witness patient without transfusions. (öffnet neues Fenster)

Lindholm J, Palmér K, Frenckner B.

Quelle‎: Perfusion 2012;27(4):332-4.

Indiziert‎: PubMed 22496111

DOI‎: 10.1177/0267659112444328

https://www.ncbi.nlm.nih.gov/pubmed/22496111 (öffnet neues Fenster)

Outcomes with the use of recombinant human erythropoietin in critically ill burn patients. (öffnet neues Fenster)

Lundy JB, Hetz K, Chung KK, Renz EM, White CE, King BT, Huzar T, Wolf SE, Blackbourne LH

Quelle‎: Am Surg 2010;76(9):951-6.

Indiziert‎: PubMed 20836341

https://www.ncbi.nlm.nih.gov/pubmed/20836341 (öffnet neues Fenster)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (öffnet neues Fenster)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Quelle‎: Intensive Care Med 2013;39(11):1896-908.

Indiziert‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (öffnet neues Fenster)

Transfusion-free treatment strategies for acute anemia in critical care. (öffnet neues Fenster)

Morgan CA, Byul Sarah S, Forest CP.

Quelle‎: JAAPA 2016;29(8):38-44.

Indiziert‎: PubMed 27467297

DOI‎: 10.1097/01.JAA.0000488695.96294.33

https://www.ncbi.nlm.nih.gov/pubmed/27467297 (öffnet neues Fenster)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (öffnet neues Fenster)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Quelle‎: J Trauma 2008;65(2):285-97.

Indiziert‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (öffnet neues Fenster)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients. (öffnet neues Fenster)

Otterman ML, Nijboer JM, van der Horst IC, van Meurs M, ten Duis HJ, Nijsten MW

Quelle‎: J Trauma 2009;67(1):121-4.

Indiziert‎: PubMed 19590320

DOI‎: 10.1097/TA.0b013e318187a848

https://www.ncbi.nlm.nih.gov/pubmed/19590320 (öffnet neues Fenster)

Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. (öffnet neues Fenster)

Pieracci FM, Henderson P, Rodney JR, Holena DN, Genisca A, Ip I, Benkert S, Hydo LJ, Eachempati SR, Shou J, Barie PS.

Quelle‎: Surg Infect (Larchmt) 2009;10(1):9-19.

Indiziert‎: PubMed 19245362

DOI‎: 10.1089/sur.2008.043

https://www.ncbi.nlm.nih.gov/pubmed/19245362 (öffnet neues Fenster)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (öffnet neues Fenster)

Posluszny JA Jr, Napolitano LM.

Quelle‎: Transfusion 2014;54(12):3026-34.

Indiziert‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (öffnet neues Fenster)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (öffnet neues Fenster)

Price S, Pepper JR, Jaggar SI.

Quelle‎: Anesth Analg 2005;101(2):325-7.

Indiziert‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (öffnet neues Fenster)

Successful rescue therapy for severe acute anemia: managing the critically ill Jehovah's Witness. (öffnet neues Fenster)

Rebel A, Beck A, Efron P, Bavry AA, Ang D.

Quelle‎: Am Surg 2015;81(6):e263-5.

Indiziert‎: PubMed 26031262

https://www.ncbi.nlm.nih.gov/pubmed/26031262 (öffnet neues Fenster)

Erythropoietin response is blunted in critically ill patients. (öffnet neues Fenster)

Rogiers P, Zhang H, Leeman M, Nagler J, Neels H, Mélot C, Vincent JL

Quelle‎: Intensive Care Med 1997;23(2):159-62.

Indiziert‎: PubMed 9069000

DOI‎: 10.1007/s001340050310

https://www.ncbi.nlm.nih.gov/pubmed/9069000 (öffnet neues Fenster)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (öffnet neues Fenster)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Quelle‎: Br J Anaesth 2005;94(4):442-4.

Indiziert‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (öffnet neues Fenster)

Management of anemia in patients who decline blood transfusion. (öffnet neues Fenster)

Shander A, Goodnough LT

Quelle‎: Am J Hematol 2018;93(9):1183-91.

Indiziert‎: PubMed 30033541

DOI‎: 10.1002/ajh.25167

https://pubmed.ncbi.nlm.nih.gov/30033541/ (öffnet neues Fenster)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (öffnet neues Fenster)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Quelle‎: Arch Surg 2012;147(3):251-5.

Indiziert‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (öffnet neues Fenster)

Intravenous iron following cardiac surgery does not increase the infection rate. (öffnet neues Fenster)

Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM.

Quelle‎: Surg Infect (Larchmt) 2006;7(4):361-6.

Indiziert‎: PubMed 16978079

DOI‎: 10.1089/sur.2006.7.361

https://www.ncbi.nlm.nih.gov/pubmed/16978079 (öffnet neues Fenster)

Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial. (öffnet neues Fenster)

Tsai TH, Lu CH, Wallace CG, Chang WN, Chen SF, Huang CR, Tsai NW, Lan MY, Sung PH, Liu CF, Yip HK

Quelle‎: Crit Care 2015;19:49.

Indiziert‎: PubMed 25888250

DOI‎: 10.1186/s13054-015-0761-8

https://www.ncbi.nlm.nih.gov/pubmed/25888250 (öffnet neues Fenster)

Pharmacotherapy for reducing RBC transfusion for patients in the ICU: a systematic review and network meta-analysis. (öffnet neues Fenster)

Yoshihiro S, Hongo T, Yamamoto M, Taito S, Kataoka Y

Quelle‎: Crit Care Med 2024;52(4):618-25.

Indiziert‎: PubMed 37962159

DOI‎: 10.1097/CCM.0000000000006114

https://pubmed.ncbi.nlm.nih.gov/37962159/ (öffnet neues Fenster)